Cargando…
The Implications for Cells of the Lipid Switches Driven by Protein–Membrane Interactions and the Development of Membrane Lipid Therapy
The cell membrane contains a variety of receptors that interact with signaling molecules. However, agonist–receptor interactions not always activate a signaling cascade. Amphitropic membrane proteins are required for signal propagation upon ligand-induced receptor activation. These proteins localize...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7177374/ https://www.ncbi.nlm.nih.gov/pubmed/32230887 http://dx.doi.org/10.3390/ijms21072322 |
_version_ | 1783525205272952832 |
---|---|
author | Torres, Manuel Rosselló, Catalina Ana Fernández-García, Paula Lladó, Victoria Kakhlon, Or Escribá, Pablo Vicente |
author_facet | Torres, Manuel Rosselló, Catalina Ana Fernández-García, Paula Lladó, Victoria Kakhlon, Or Escribá, Pablo Vicente |
author_sort | Torres, Manuel |
collection | PubMed |
description | The cell membrane contains a variety of receptors that interact with signaling molecules. However, agonist–receptor interactions not always activate a signaling cascade. Amphitropic membrane proteins are required for signal propagation upon ligand-induced receptor activation. These proteins localize to the plasma membrane or internal compartments; however, they are only activated by ligand-receptor complexes when both come into physical contact in membranes. These interactions enable signal propagation. Thus, signals may not propagate into the cell if peripheral proteins do not co-localize with receptors even in the presence of messengers. As the translocation of an amphitropic protein greatly depends on the membrane’s lipid composition, regulation of the lipid bilayer emerges as a novel therapeutic strategy. Some of the signals controlled by proteins non-permanently bound to membranes produce dramatic changes in the cell’s physiology. Indeed, changes in membrane lipids induce translocation of dozens of peripheral signaling proteins from or to the plasma membrane, which controls how cells behave. We called these changes “lipid switches”, as they alter the cell’s status (e.g., proliferation, differentiation, death, etc.) in response to the modulation of membrane lipids. Indeed, this discovery enables therapeutic interventions that modify the bilayer’s lipids, an approach known as membrane-lipid therapy (MLT) or melitherapy. |
format | Online Article Text |
id | pubmed-7177374 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-71773742020-04-28 The Implications for Cells of the Lipid Switches Driven by Protein–Membrane Interactions and the Development of Membrane Lipid Therapy Torres, Manuel Rosselló, Catalina Ana Fernández-García, Paula Lladó, Victoria Kakhlon, Or Escribá, Pablo Vicente Int J Mol Sci Review The cell membrane contains a variety of receptors that interact with signaling molecules. However, agonist–receptor interactions not always activate a signaling cascade. Amphitropic membrane proteins are required for signal propagation upon ligand-induced receptor activation. These proteins localize to the plasma membrane or internal compartments; however, they are only activated by ligand-receptor complexes when both come into physical contact in membranes. These interactions enable signal propagation. Thus, signals may not propagate into the cell if peripheral proteins do not co-localize with receptors even in the presence of messengers. As the translocation of an amphitropic protein greatly depends on the membrane’s lipid composition, regulation of the lipid bilayer emerges as a novel therapeutic strategy. Some of the signals controlled by proteins non-permanently bound to membranes produce dramatic changes in the cell’s physiology. Indeed, changes in membrane lipids induce translocation of dozens of peripheral signaling proteins from or to the plasma membrane, which controls how cells behave. We called these changes “lipid switches”, as they alter the cell’s status (e.g., proliferation, differentiation, death, etc.) in response to the modulation of membrane lipids. Indeed, this discovery enables therapeutic interventions that modify the bilayer’s lipids, an approach known as membrane-lipid therapy (MLT) or melitherapy. MDPI 2020-03-27 /pmc/articles/PMC7177374/ /pubmed/32230887 http://dx.doi.org/10.3390/ijms21072322 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Torres, Manuel Rosselló, Catalina Ana Fernández-García, Paula Lladó, Victoria Kakhlon, Or Escribá, Pablo Vicente The Implications for Cells of the Lipid Switches Driven by Protein–Membrane Interactions and the Development of Membrane Lipid Therapy |
title | The Implications for Cells of the Lipid Switches Driven by Protein–Membrane Interactions and the Development of Membrane Lipid Therapy |
title_full | The Implications for Cells of the Lipid Switches Driven by Protein–Membrane Interactions and the Development of Membrane Lipid Therapy |
title_fullStr | The Implications for Cells of the Lipid Switches Driven by Protein–Membrane Interactions and the Development of Membrane Lipid Therapy |
title_full_unstemmed | The Implications for Cells of the Lipid Switches Driven by Protein–Membrane Interactions and the Development of Membrane Lipid Therapy |
title_short | The Implications for Cells of the Lipid Switches Driven by Protein–Membrane Interactions and the Development of Membrane Lipid Therapy |
title_sort | implications for cells of the lipid switches driven by protein–membrane interactions and the development of membrane lipid therapy |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7177374/ https://www.ncbi.nlm.nih.gov/pubmed/32230887 http://dx.doi.org/10.3390/ijms21072322 |
work_keys_str_mv | AT torresmanuel theimplicationsforcellsofthelipidswitchesdrivenbyproteinmembraneinteractionsandthedevelopmentofmembranelipidtherapy AT rossellocatalinaana theimplicationsforcellsofthelipidswitchesdrivenbyproteinmembraneinteractionsandthedevelopmentofmembranelipidtherapy AT fernandezgarciapaula theimplicationsforcellsofthelipidswitchesdrivenbyproteinmembraneinteractionsandthedevelopmentofmembranelipidtherapy AT lladovictoria theimplicationsforcellsofthelipidswitchesdrivenbyproteinmembraneinteractionsandthedevelopmentofmembranelipidtherapy AT kakhlonor theimplicationsforcellsofthelipidswitchesdrivenbyproteinmembraneinteractionsandthedevelopmentofmembranelipidtherapy AT escribapablovicente theimplicationsforcellsofthelipidswitchesdrivenbyproteinmembraneinteractionsandthedevelopmentofmembranelipidtherapy AT torresmanuel implicationsforcellsofthelipidswitchesdrivenbyproteinmembraneinteractionsandthedevelopmentofmembranelipidtherapy AT rossellocatalinaana implicationsforcellsofthelipidswitchesdrivenbyproteinmembraneinteractionsandthedevelopmentofmembranelipidtherapy AT fernandezgarciapaula implicationsforcellsofthelipidswitchesdrivenbyproteinmembraneinteractionsandthedevelopmentofmembranelipidtherapy AT lladovictoria implicationsforcellsofthelipidswitchesdrivenbyproteinmembraneinteractionsandthedevelopmentofmembranelipidtherapy AT kakhlonor implicationsforcellsofthelipidswitchesdrivenbyproteinmembraneinteractionsandthedevelopmentofmembranelipidtherapy AT escribapablovicente implicationsforcellsofthelipidswitchesdrivenbyproteinmembraneinteractionsandthedevelopmentofmembranelipidtherapy |